Business context and reporting period
The supplied filing is Griffin-American Healthcare REIT IV, Inc.’s Form 10-K for the fiscal year ended December 31, 2015—not a filing under the name American Healthcare REIT, Inc. The company was incorporated in January 2015 and had not commenced material operations or acquired properties by year-end. It intends to invest primarily in healthcare real estate and to elect REIT status beginning in 2016 or when material operations begin.
The filing describes a best-efforts public offering that became effective February 16, 2016, after the reporting period: up to $3.0 billion in primary shares at $10.00 each and up to $150 million through a distribution reinvestment plan at $9.50 per share. No offering subscriptions had been received as of December 31, 2015.
Financial and operating metrics
| Metric | Reported amount or status |
|---|---|
| Total assets / cash, December 31, 2015 | $202,000 |
| Total equity | $202,000, including $200,000 stockholders’ equity and $2,000 noncontrolling interest |
| Liabilities and debt | No liabilities or outstanding debt reported |
| Revenue, profit, and operating cash flow | No operating results; the company had not commenced operations |
| Cash flow | $202,000 provided by financing activities: $200,000 from share issuance and $2,000 from an operating-partnership contribution |
| Properties, investments, and distributions | None owned or purchased; no distributions paid |
There is no prior comparable operating period because the company was formed in 2015 and had no operating results. The statements were audited by Deloitte & Touche LLP, which issued an unqualified opinion on the financial statements.
Changes, outlook, and material considerations
- Post-year-end developments: The offering and DRIP became effective in February 2016; the company also adopted an incentive plan and share repurchase plan. These developments occurred after December 31, 2015.
- Plans and funding: The company expects to rely on offering proceeds, future operating cash flow, and borrowings to fund acquisitions, expenses, and potential distributions. It anticipates long-term leverage generally not exceeding 50% of investment market value after an initial operating phase; its charter requires independent-director approval for borrowing above 300% of defined net assets.
- Distributions and REIT status: No distribution rate or operating guidance is provided. The company had not yet qualified as a REIT; it intends to elect REIT treatment in 2016 or when material operations commence. REIT qualification generally requires distributing at least 90% of annual taxable income, excluding net capital gains.
- Liquidity and valuation: The shares had no established public trading market. The reported estimated value of $10.00 per share was based on the later offering price, not an independent appraisal or an estimate of liquidation proceeds. Repurchases are restricted, discretionary, and funded only from DRIP proceeds.
- Key risks: This is a blind-pool offering with no identified investments, no operating history, and dependence on raising capital and the external advisor. Other material risks include illiquidity, possible use of offering proceeds or borrowings to fund distributions, acquisition and healthcare-sector risks, leverage and interest-rate exposure, sponsor conflicts and fees, and failure to qualify as a REIT.
- Contingencies and unusual items: No material litigation, debt, contractual obligations, or off-balance-sheet arrangements were reported at year-end. The advisor had incurred approximately $1.606 million of offering expenses by year-end; these were not recorded as company liabilities because they were not payable by the company until the minimum offering was reached.
Important facts for investors to verify
- Confirm the issuer’s legal identity: the filing names Griffin-American Healthcare REIT IV, Inc., which differs from the company specified in the request.
- Verify offering progress, amounts actually raised, and whether the minimum offering was reached and funds released from escrow.
- Review subsequent property acquisitions, deployment of proceeds, recurring expenses, and any distributions, including whether distributions are supported by operating cash flow.
- Assess the independent valuation behind any later estimated share value; the $10.00 figure in this filing is the offering price, not an appraisal.
- Review the external-advisor fee and incentive structure, related-party transactions, and how healthcare investment opportunities are allocated among affiliated programs.
- Track REIT qualification, debt and leverage, liquidity restrictions, and any changes to the share repurchase plan.